Nabriva Therapeutics plc·4

Aug 4, 4:08 PM ET

Schranz Jennifer 4

4 · Nabriva Therapeutics plc · Filed Aug 4, 2020

Insider Transaction Report

Form 4
Period: 2020-07-31
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-07-31$0.76/sh301$229168,444 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4